﻿<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="http://medrxiv.org">
<admin:errorReportsTo rdf:resource="mailto:medrxiv@cshlpress.edu"/>
<title>medrxiv Subject Collection: Epidemiology</title>
<link>http://medrxiv.org</link>
<description>
This feed contains articles for medRxiv Subject Collection "Epidemiology"
</description>

<items>
<rdf:Seq>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26368055v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26367651v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26368022v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26367950v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26368017v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26367966v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367924v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367979v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367973v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367976v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367900v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367977v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367906v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367852v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367940v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367922v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367975v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26368016v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367954v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367949v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.13.26367733v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367860v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367886v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367750v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.12.26367895v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367258v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.10.26367785v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367828v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.11.26367838v1?rss=1"/>
<rdf:li rdf:resource="https://www.medrxiv.org/content/10.64898/2026.11.10.26367783v1?rss=1"/>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>medrxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>medrxiv</title>
<url>https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png</url>
<link>http://medrxiv.org</link>
</image>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26368055v1?rss=1">
<title>
<![CDATA[
Multi-omics models for hypertension prediction using blood pressure PRS and omics scores 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26368055v1?rss=1
</link>
<description><![CDATA[
Background: Hypertension is a major modifiable risk factor for cardiovascular disease, yet the relative contributions of proteomic (ProtS), metabolomic (MetS), and polygenic risk scores (PRS) to incident hypertension risk remain incompletely characterized. Methods: We developed ProtS and MetS for systolic (SBP) and diastolic blood pressure (DBP), and hypertension using Elastic Net regression in the Multi-Ethnic Study of Atherosclerosis (MESA). We incorporated these scores with previously developed BP PRSs into 5 incremental XGBoost models, with external validation in the Jackson Heart Study (JHS). We further applied transfer learning to adapt the MESA-derived models to JHS. Elastic Net selected proteins were prioritized using Mendelian randomization, colocalization, and functional analyses. Results: In MESA, model discrimination improved with the addition of omics scores, with the combined model achieving an area under the curve (AUC) of 0.72 compared with 0.63 for the clinical baseline model. In JHS, ProtS showed the highest AUC of 0.68 and the smallest cross-cohort performance decline, compared to MetS and PRS. Incorporating measured SBP and DBP substantially improved discrimination, with the PRS+BP model achieving an AUC of 0.80 in MESA and the baseline+BP model achieving an AUC of 0.74 in JHS. Among JHS participants with normal baseline BP, ProtS provided the strongest discrimination among models without measured BP (AUC = 0.62), while PRS+BP model achieved an AUC of 0.69. Leaf-weight refreshing consistently improved calibration in JHS while preserving discrimination. Mendelian randomization identified 77 proteins associated with BP traits or hypertension, involved in vascular, inflammatory, renal, and natriuretic pathways. Conclusions: ProtS demonstrated superior predictive performance and cross-cohort transferability among the omics modalities evaluated, while measured BP remained the strongest predictors of incident hypertension. Proteomic and genetic information may provide complementary biological signals for identifying individuals at elevated hypertension risk, particularly before clinically elevated BP is detectable.
]]></description>
<dc:creator><![CDATA[ Wang, Z., Hrytsenko, Y., Almogy, S., Spitzer, B. W., Purushotham, Y., Taylor, K., Lin, H. J. J., Tahir, U. A., Raffield, L. M., Rich, S., Rotter, J., Chen, Z. Z., Sofer, T. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26368055</dc:identifier>
<dc:title><![CDATA[Multi-omics models for hypertension prediction using blood pressure PRS and omics scores]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26367651v1?rss=1">
<title>
<![CDATA[
Beyond National Averages: Social Contact Patterns in the Upper Midwest 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26367651v1?rss=1
</link>
<description><![CDATA[
Background: Social contact surveys measure how individuals interact with each other, which directly influences disease transmission dynamics. The COVID-19 pandemic substantially altered how people live and work, highlighting the need for up-to-date and sub-national estimates of social contact patterns to inform disease modeling and public health planning. Methods: The Midwest Analytics & Disease Modeling Center (MADMC) conducted an opt-in social contact survey of upper Midwest residents, with about 60% of participants drawn from Minnesota. Participants reported all interpersonal contacts during the previous day, including the age of their contacts allowing for the analysis of mixing patterns. Detailed demographic information about the participants was also collected, allowing for additional subgroup analyses of contact patterns. Results: Participants in our sample had an average of 6.8 contacts per day (IQR: 2.0 - 8.0), which is within the range of recent post-pandemic US national and European estimates. Contacts varied across demographic groups, with those attending work or school in-person reporting the highest number of contacts. Mixing across most age group pairs was a little lower than in comparable national survey except for younger age groups, who had substantially higher rates of contact with same-age peers. Differences in the contact matrices alone were associated with a 6.7% difference in estimated basic reproduction number(R0). Near the epidemic threshold, even this modest difference could meaningfully affect transmission dynamics. These effects may be amplified or attenuated by pathogen-specific age patterns of susceptibility and infectiousness, leading to larger or smaller differences in R0 estimates derived from national versus regional mixing patterns. Conclusions: These findings provide empirical evidence on post-pandemic social contact patterns in the United States and highlight the potential implications of regional variation in social mixing for infectious disease transmission. The mean 6.8 daily contacts is consistent with evidence of persistent changes in daily routines following the pandemic. Incorporating contemporary, region-specific contact patterns into transmission models may improve their ability to capture geographic variation in transmission risk and inform epidemic forecasting.
]]></description>
<dc:creator><![CDATA[ Dorelien, A., Carlson, M., Wheatley, M. M., Erickson, L., Morris, K., Sweet, K., Enns, E. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26367651</dc:identifier>
<dc:title><![CDATA[Beyond National Averages: Social Contact Patterns in the Upper Midwest]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26368022v1?rss=1">
<title>
<![CDATA[
Wastewater sequence data reveal national and cross-border virus transmission dynamics 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26368022v1?rss=1
</link>
<description><![CDATA[
Spatial epidemic models estimate disease transmission counts between populations using human mobility data, but location-to-location transmission is rarely observed directly. To address this gap, we develop mutation-counting methods to infer transmission structure from viral genetic variation measured in wastewater. In epidemic simulations with known transmission networks, our primary estimator robustly recovers spatial structure under realistic mutation-detection limits. Applied to spatiotemporal SARS-CoV-2 wastewater data from Austria, the method reveals strong seasonal reorganization, with inferred transmission becoming more geographically localized in winter and more dispersed in summer. We further identify locations with systematically higher or lower connectivity than expected from commuting, with temporal changes coinciding with regional restrictions, reopening and tourism. We then test whether such inference remains possible across national borders, recovering coherent spatial structure and temporal variation in connectivity between Austria, Switzerland and Liechtenstein. These results establish wastewater sequence data as a promising complement to mobility data for monitoring spatial transmission and detecting changes in epidemic spread associated with seasonality and interventions.
]]></description>
<dc:creator><![CDATA[ Odor, G., Endler, L., Amman, F., Bergthaler, A. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26368022</dc:identifier>
<dc:title><![CDATA[Wastewater sequence data reveal national and cross-border virus transmission dynamics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26367950v1?rss=1">
<title>
<![CDATA[
Emergent Heterogeneity in Compartmental Disease Models 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26367950v1?rss=1
</link>
<description><![CDATA[
Heterogeneity in infectious disease spread reshapes the risk and severity of outbreaks. This heterogeneity can arise from intrinsic individual-level differences in susceptibility, contact patterns, and infectious durations. Heterogeneity can also emerge from disease dynamics in a canonically homogeneous population, due to the fact that individuals randomly become infected at different times, recover after different intervals, and have access to different numbers of susceptible individuals. Here, we explore the mechanisms generating emergent heterogeneity by analyzing secondary case distributions within the SIR model. We show numerically and prove analytically that the variation in secondary cases, calculated over the course of the epidemic, does not change with R0. This is in contrast to the increasing variation in secondary cases in the linearized SIR model, often used to study heterogeneity at the beginning of an outbreak. When we consider forward cohorts of individuals infected at the same time, between-cohort variation increases as R0 increases, while within-cohort variation decreases. We show that these effects balance exactly, leading to the invariance of the variation in secondary cases with respect to R0. These results demonstrate the importance of considering emergent, as well as intrinsic, variation between individuals and of considering heterogeneity of transmission spread over the whole epidemic cycle, including substantive dynamical effects that appear even in the initial outbreak phase.
]]></description>
<dc:creator><![CDATA[ Roswell, M., Aghaeeyan, A., Goel, T., Beckett, S. J., Weitz, J. S., Dushoff, J. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26367950</dc:identifier>
<dc:title><![CDATA[Emergent Heterogeneity in Compartmental Disease Models]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26368017v1?rss=1">
<title>
<![CDATA[
Nirsevimab effectiveness against RSV hospitalizations in children 8-23 months at risk of severe RSV 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26368017v1?rss=1
</link>
<description><![CDATA[
Importance: Respiratory syncytial virus (RSV) is a leading cause of hospitalization in high-risk young children during their second RSV season. Nirsevimab, a long-acting monoclonal antibody against RSV, is recommended for some children who are at increased risk for severe RSV and entering their second RSV season to prevent severe RSV disease. Because of limited eligibility criteria for second season nirsevimab, estimating its effectiveness is challenging. Objective: We evaluated nirsevimab effectiveness against RSV-associated hospitalizations among young children eligible to receive nirsevimab during their second RSV season. Design: This retrospective case control study with a test-negative design was conducted during the 2024-2025 and 2025-2026 RSV seasons. Setting: Enrollment was in 26 hospitals across 24 U.S. states. Participants: Children eligible for nirsevimab during their second RSV season (as recommended in August 2023) were included. Nirsevimab-eligible children 8-23 months old hospitalized with respiratory symptoms were enrolled. Case-patients tested positive for RSV; control-patients tested negative for RSV. Exposures: Receipt of nirsevimab before or during the second RSV season and at least 7 days before symptom onset. Outcomes and measures: RSV-associated hospitalization. We estimated nirsevimab effectiveness using multivariable logistic regression adjusted for age, month and year of hospitalization, census region, and sex comparing the odds of second season nirsevimab receipt among case- and control-patients. Results: One hundred six case-patients and 125 control-patients were analyzed. Distributions of age, sex, race and ethnicity, and region were similar in case- and control-patients. Most case- and control-patients were eligible for nirsevimab because of chronic lung disease of prematurity (84.0% and 69.6%, respectively). Overall, 21 (19.8%) of case-patients and 53 (42.4%) of control-patients received nirsevimab. Adjusted nirsevimab effectiveness against RSV-associated hospitalizations was 78.1% (95% CI, 55.2%-89.3%); the median interval from nirsevimab receipt to symptom onset was 66.5 days (IQR = 30-96 days). Effectiveness was estimated to be higher if nirsevimab was received 8-59 days before symptom onset (88.5%, 95% CI, 63.4%-96.4%). Conclusions: This analysis provides real-world estimates of substantial nirsevimab effectiveness against RSV-associated hospitalizations for high-risk U.S. children in their second RSV season These data support recommendations for nirsevimab as a preventive strategy in this population.
]]></description>
<dc:creator><![CDATA[ Simeone, R. M., Newhams, M. M., Payne, A. B., Orzel-Lockwood, A. O., Calixte, J., Halasa, N., Kamidani, S., Crandall, H., Irby, K., Maddux, A. B., Zerr, D., Guzman-Cottrill, J., Schuster, J., Chiotos, K., Kong, M., Staat, M. A., Hume, J., Stockwell, M. S., Cameron, M., Hogan, A. H., Chauhan, J., Biggs, A., Levy, E. R., Bhumbra, S., Walker, T. C., Marupudi, N. K., Prahl, M. K., Michelson, K. N., Martin, L., Brandford, T., Randolph, A., Campbell, A. P., Overcoming RSV Network investigators ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26368017</dc:identifier>
<dc:title><![CDATA[Nirsevimab effectiveness against RSV hospitalizations in children 8-23 months at risk of severe RSV]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26367966v1?rss=1">
<title>
<![CDATA[
Population-level indirect effects of HPV vaccination in high-income settings: a Bayesian modelling study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26367966v1?rss=1
</link>
<description><![CDATA[
Background Human papillomavirus (HPV) vaccination provides direct protection to vaccinated individuals, but also indirectly protects unvaccinated individuals through reduced HPV transmission. Mechanistic transmission models that predict the magnitude of such effects have been crucial to informing vaccination strategies. However, nearly two decades of post-vaccination experience in high-income countries now allow us to empirically characterise how population-level indirect effects vary with vaccine coverage, time since vaccine introduction, and age. Methods We synthesised studies reporting HPV16/18 prevalence before and after vaccine introduction in high-income settings between 2007 and 2025. Indirect effects were estimated as the observed reduction in HPV16/18 prevalence after accounting for expected direct vaccine protection. We used a Bayesian hierarchical model to examine associations with vaccine coverage, time since vaccine introduction, and age at effect assessment across routine, catch-up, and non-targeted vaccination groups. XGBoost was used as a complementary, non-parametric approach. Findings Data from 11 high-income settings were included. Indirect effects increased during the first five to eight years after vaccine introduction and then remained relatively stable. Indirect effects generally decreased with increasing vaccine coverage. Patterns with age differed across vaccination groups. In the routine group, indirect effects increased during adolescence and remained positive at older observed ages. In the catch-up group, indirect effects decreased with age and approached zero or became negative after approximately age 25 years. XGBoost identified similar non-linear patterns. Interpretation Indirect protection against HPV16/18 develops gradually after vaccine introduction and varies with vaccine coverage, age, and vaccination group. This empirical approach can complement transmission models by using real-world evidence to characterise population-level indirect protection. However, making predictions outside the populations and ranges represented in the data should be done cautiously.
]]></description>
<dc:creator><![CDATA[ Wang, R., Jit, M. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26367966</dc:identifier>
<dc:title><![CDATA[Population-level indirect effects of HPV vaccination in high-income settings: a Bayesian modelling study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367924v1?rss=1">
<title>
<![CDATA[
An integrative eco-entomovirological study of Culicoides species associated with Oropouche virus in Colombia 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367924v1?rss=1
</link>
<description><![CDATA[
Background Oropouche virus (OROV) causes recurrent outbreaks in South America, including Colombia. Although Culicoides paraensis is the principal recognized urban vector, the potential involvement of other Culicoides species remains incompletely understood. In Colombia, studies combining viral detection, host-feeding behavior, and ecological suitability are scarce. Methodology We investigated Culicoides communities in urban and peri-urban environments of Puerto Carreno, Vichada, during two seasonal transitions. Species identification combined morphology and COI DNA barcoding, and blood-meal sources were identified using vertebrate molecular markers. OROV RNA was assessed by RT-qPCR targeting the L and S genomic segments, and maximum likelihood prevalence estimates with 95% confidence intervals were calculated accounting for unequal pool sizes, including a conservative estimate based on concordant detection of both targets. Selected positive samples underwent multiplex amplicon sequencing of fragments from all three OROV genomic segments (L, M, and S) using Oxford Nanopore Technology, followed by consensus reconstruction and phylogenetic analysis. Ecological suitability models were compared with reported OROV case distributions. Principal Findings We collected 1,639 specimens representing 11 taxa, eight supported by COI barcoding. C. insignis accounted for more than 70% of captures and was the only taxon collected in urban settings. OROV RNA was detected in C. insignis, C. pusillus, and C. ignacioi. In C. insignis, concordant detection of the L and S molecular targets yielded an estimated prevalence of 3.61 per 1,000 individuals (95% CI: 0.94-9.60). Nanopore sequencing recovered OROV-derived fragments spanning up to 656 nt across the L, M, and S genomic segments. Shorter fragments supported molecular identification, while phylogenetic analysis of a 656-nt M-segment region recovered from C. insignis and C. pusillus placed both sequences within a group containing viruses associated with the recent South American outbreak, although partial genomic coverage precluded formal lineage assignment. Blood-meal analyses identified feeding on humans, horses, and pigs in C. insignis; humans and horses in C. pusillus; and horses in C. ignacioi. Ecological models identified distinct environmental associations among species, and predicted suitability for overlapping portions of regions reporting OROV cases. Administrative-scale concordance was heterogeneous. Conclusions The integration of molecular, host-feeding, and ecological evidence highlights C. insignis, C. pusillus, and C. ignacioi as species of epidemiological interest in the context of OROV circulation in Colombia. These findings expand current knowledge of OROV-associated Culicoides diversity and provide a basis for targeted entomological surveillance and experimental studies to clarify their potential roles in virus transmission.
]]></description>
<dc:creator><![CDATA[ Mantilla, J. S., Garcia-Guzman, S., Salcedo-Amortegui, C. J., Calvo-Tapiero, E. P., Cardozo, D. A., Castellanos, J. E. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367924</dc:identifier>
<dc:title><![CDATA[An integrative eco-entomovirological study of Culicoides species associated with Oropouche virus in Colombia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367979v1?rss=1">
<title>
<![CDATA[
Aging, Structural, and Neighborhood-Environmental Correlates of Cardiovascular-Kidney-Metabolic Risk Factor Burden Across U.S. Census Tracts 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367979v1?rss=1
</link>
<description><![CDATA[
Background. The American Heart Association defined Cardiovascular-Kidney-Metabolic (CKM) syndrome in 2023. Census-tract studies often examined one condition without spatial modeling. It is unclear where combined Stage 1-2 burden concentrates and how it relates to aging, environment, and socioeconomic conditions. Methods. We built a CKM burden index for 70,336 tracts from five CDC PLACES crude prevalences (obesity, diabetes, hypertension, hypercholesterolemia, chronic kidney disease) and compared it with NHANES 2017-2020. In 69,530 contiguous-U.S. tracts, we fit Bayesian spatial (BYM2) models with demographic, socioeconomic, and environmental predictors and aging x environment interactions, plus descriptive machine learning. The primary model excluded behavioral measures sharing the outcome's BRFSS source; a second added them. Credible intervals (CrIs) are conditional on PLACES estimates. Results. Agreement with NHANES was modest. Burden clustered spatially (Moran's I = 0.657) and highest in the South. Behavioral measures had the largest machine-learning importance (52.6%), partly from shared sourcing. Each percentage-point increase in adults 65 years was associated with 0.112 units higher burden (95% CrI 0.111-0.113) outside low-income, low-access (LILA) tracts. LILA tracts had 0.10-0.14 units higher burden from the 25th aging percentile but not consistently in the youngest decile. Aging and socioeconomic associations held across sensitivity analyses. The primary model's residual Southern excess approached zero after adding behavioral measures, which may reflect shared measurement, real differences in these behaviors, or both. Conclusions. CKM burden is spatially clustered and highest in the South. LILA tracts had modestly higher burden above the youngest tracts. These cross-sectional estimates support area-level surveillance and needs assessment.
]]></description>
<dc:creator><![CDATA[ Batobara, A., Alfaraidhy, M., Tanriover, B., Liu, Y., Damluji, A. A., Vest, A. R., Lim, C. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367979</dc:identifier>
<dc:title><![CDATA[Aging, Structural, and Neighborhood-Environmental Correlates of Cardiovascular-Kidney-Metabolic Risk Factor Burden Across U.S. Census Tracts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367973v1?rss=1">
<title>
<![CDATA[
Gut microbiome associations with incident cardiovascular disease in Nordic populations 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367973v1?rss=1
</link>
<description><![CDATA[
Background: The gut microbiome is an emerging risk factor for cardiovascular disease. However, there is a lack of large-scale metagenomic studies with replication that identify gut microbial features associated with incident cardiovascular disease (CVD). Methods: We tested for gut microbiome associations with CVD using metagenomes from stool samples in a discovery-replication framework across four large prospective Nordic cohorts with 635 incident CVD in 11,604 participants in the discovery cohort and 2,309 incident CVD in 20,965 participants combined across three replication cohorts. Results: Higher Shannon diversity index and species richness were consistently associated with a lower risk of incident CVD. In addition, the relative abundance of nine species and eleven bacterial functional modules showed reproducible associations with incident CVD in the discovery cohort and in a meta-analysis of the three replication cohorts. We identified a female-specific gut microbiota-related pathway involving the prevalent oral-gut species Rothia mucilaginosa_A, enriched among denture users, thus serving as a proxy for longstanding poor oral health. Mendelian randomization analysis supported a causal effect of denture use on increased relative abundance of Rothia mucilaginosa_A. This pathway was linked to increased CVD risk through altered gut microbial manganese transport, elevated circulating imidazole propionate levels, and increased levels of systemic inflammation biomarkers. The second pathway involved both ?-diversity metrics and the remaining eight species, all of which were strongly associated with multiple markers of metabolic syndrome and with bacterial pathways related to purine metabolism, microbial stress responses, altered redox balance, ascorbic acid degradation, and branched chain amino acid biosynthesis. Conclusions: These findings demonstrate that gut microbiota diversity, specific taxa, and functional pathways provide new insights into the underlying biology of CVD. Furthermore, these findings suggest that the link between poor oral health and cardiovascular disease may, at least partly, operate through altered gut microbiota.
]]></description>
<dc:creator><![CDATA[ Wolford, B. N., Larsson, S. C., Nethander, M., Lawenius, L., Pertiwi, K., Kambur, O., Coward, E., Gynnild, M. N. N., Giskeodegard, G. F., Asvold, B. O., Grahnemo, L., Erkorkmaz, B. A., Engström, G., Smith, J. G., Salomaa, V., Dekkers, K., Ärnlöv, J., Havulinna, A. S., Volpiano, C. G., Meric, G., Niiranen, T. J., Orho-Melander, M., Fall, T., Ohlsson, C., Hveem, K. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367973</dc:identifier>
<dc:title><![CDATA[Gut microbiome associations with incident cardiovascular disease in Nordic populations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367976v1?rss=1">
<title>
<![CDATA[
The gut microbiome and incident atherosclerotic cardiovascular events: Prospective analyses in three Swedish cohorts 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367976v1?rss=1
</link>
<description><![CDATA[
Background: Variation in the gut microbiome composition has been associated with atherosclerotic cardiovascular disease (ASCVD) in case-control designs. We aimed to investigate associations with incident ASCVD events applying a prospective design to reduce the impact of reverse causality. Methods: We assessed associations between gut microbiome features measured by shotgun metagenomic sequencing and incident total ASCVD, ischemic heart disease (IHD) and ischemic stroke, including fatal and non-fatal events as defined by registry follow-up in 17,216 participants from three Swedish population-based cohorts (SCAPIS, SIMPLER, and MOS). Results from Cox proportional hazards regression models adjusted for demographic, and lifestyle factors, medication, and prevalent diabetes were combined across cohorts using a fixed-effect meta-analysis accounting for multiple testing. Associations were tested for replication in HUNT and FINRISK. Results: During a median of 6-8 y follow-up, 769 incident ASCVD events occurred. Species diversity was inversely associated with ASCVD and IHD, with a hazard ratio for IHD of 0.86 per SD increase in species richness (95% CI: 0.79-0.95). Sixty-eight common species (i.e., present in ?30% individuals) were associated with incident IHD after adjusting for sex and birth country, but only eight remained in fully adjusted models, including Ruminococcus_B gnavus. Among others, inverse associations were observed for SFEL01 sp004557245 and Fimadaptatus sp900553645 from Christensenellales, an order in which butyrate production has been reported. Streptococcus mutans and Limosilactobacillus fermentum, oral-associated species previously associated with coronary atherosclerosis, were associated with a higher risk of incident IHD, which remained after adjustment for dental health. Replication analysis in the HUNT study supported the finding for S. mutans. No associations were observed with ischemic stroke. Conclusions: Gut species diversity and specific species abundance were associated with incident IHD, providing evidence supporting a protective role of two Christensenellales species and an adverse role of oral species and R. gnavus in the development of IHD.
]]></description>
<dc:creator><![CDATA[ Pertiwi, K., Hammar, U., Dekkers, K., Coward, E., Kambur, O., Baldanzi, G., Delgado-Velandia, M., Sayols-Baixeras, S., Yuan, S., Persson, P., Gabrielsson, D., Miari, M., Volpiano, C. G., Meric, G., Jönsson, D., Engström, G., Smith, J. G., Michaëlsson, K., Melander, O., Ärnlöv, J., Knight, R., Hofmann, R., Niiranen, T. J., Havulinna, A. S., Salomaa, V., Hveem, K., Ohlsson, C., Orho-Melander, M., Larsson, S. C., Fall, T. ]]></dc:creator>
<dc:date>2026-11-16</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367976</dc:identifier>
<dc:title><![CDATA[The gut microbiome and incident atherosclerotic cardiovascular events: Prospective analyses in three Swedish cohorts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367900v1?rss=1">
<title>
<![CDATA[
Projected prevalence and number of persons with diagnosed type 2 diabetes by socioeconomic position in Germany between 2022 and 2060 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367900v1?rss=1
</link>
<description><![CDATA[
Background: Current projections of the prevalence and number of persons with type 2 diabetes by socioeconomic position (SEP) are lacking for Germany. This study aims to project age-specific type 2 diabetes prevalence in Germany by sex and SEP between 2022 and 2060. Methods: We used a partial differential equation (PDE) based on the illness-death model to project age-specific type 2 diabetes prevalence by sex and SEP between 2022 and 2060. The PDE describes the relationship between prevalence, incidence, all-cause mortality and the mortality rate ratio (MRR) of individuals with vs. without type2 diabetes considering age, calendar year and SEP. SEP was measured by quintiles of the German Index of Socioeconomic Deprivation (GISD). Baseline prevalence, incidence, and MRR in 2022 were derived from statutory health insurance data (~85% of the German population). Projected prevalence was multiplied by population projections from the German Federal Statistical Office to estimate the number of persons with diabetes. Results: Type 2 diabetes prevalence increases with age, peaking between 80 and 90 years. Between 2022 and 2060, age-specific prevalence is projected to increase for both sexes across all SEP groups. SEP-related disparities persisted with largest differences between the highest (5th GISD quintile) and lowest (1st GISD quintile) SEP group. The number of persons with type 2 diabetes is projected to rise from 8.4 million in 2022 to between 11.2 and 19.2 million in 2060. Conclusions: Between 2022 and 2060, age-specific type 2 diabetes prevalence is projected to increase with increasing socioeconomic inequalities.
]]></description>
<dc:creator><![CDATA[ Piedboeuf-Potyka, K., Hering, R., Schulz, M., Mackowiak, M., Brinks, R., Hoyer, A., Wirth, M., Toennies, T. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367900</dc:identifier>
<dc:title><![CDATA[Projected prevalence and number of persons with diagnosed type 2 diabetes by socioeconomic position in Germany between 2022 and 2060]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367977v1?rss=1">
<title>
<![CDATA[
Investigating Differential Changes in Cardiovascular Mortality by Documented diabetes in the United States Before and During the COVID-19 Pandemic: A Comparative Time-Series Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367977v1?rss=1
</link>
<description><![CDATA[
Background: Whether diabetes modified pandemic-related changes in cardiovascular disease (CVD) mortality remains uncertain. We examined differential changes in US CVD mortality among deaths with versus without diabetes documented on the death certificate. Methods: We analyzed CDC WONDER Multiple Cause of Death data from 2005 to 2024, identifying deaths with CVD as the underlying cause among adults aged 25 years. Cohorts were CVD deaths with diabetes documented as a contributing cause (CVD+DM) and CVD deaths without documented diabetes. Because pre-2020 trajectories differed, the primary comparison of age-adjusted rates used a comparative interrupted time-series model allowing cohort-specific pre-2020 trends. Difference-in-differences estimates (2015-2019 vs 2020-2024) were descriptive. Results: CVD+DM mortality declined from 43.1 per 100,000 in 2005 to 34.3 in 2019 and was 38.4 in 2024; mortality without documented diabetes declined from 398.7 to 296.6 and was 289.8. In the primary analysis, CVD+DM mortality showed a 13.1% greater relative level increase at 2020 (95% CI, 10.4%-15.9%), with no significant differential change in slope thereafter. Descriptively, the ratio of rate ratios was 1.16, and the absolute difference-in-differences was 5.0 per 100,000. Conclusions: After accounting for cohort-specific pre-2020 trends, CVD mortality with documented diabetes showed a greater relative increase at the 2020 transition. These findings describe differential mortality patterns rather than a causal effect of diabetes or the pandemic. Keywords: Cardiovascular mortality; Diabetes; COVID-19; Difference-in-differences; Preventive Cardiology Nonstandard Abbreviations and Acronyms AAMR: age-adjusted mortality rate APC: annual percentage change CITS: comparative interrupted time-series CVD+DM: cardiovascular disease deaths with diabetes documented as contributing cause DID: differences-in-differences DM: diabetes mellitus
]]></description>
<dc:creator><![CDATA[ Ghani, M. U., Chang, H., Shuhag, S., Kamath, S., Chughtai, S., Bhuiyan, M. A. N., Rodriguez, C. J. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367977</dc:identifier>
<dc:title><![CDATA[Investigating Differential Changes in Cardiovascular Mortality by Documented diabetes in the United States Before and During the COVID-19 Pandemic: A Comparative Time-Series Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367906v1?rss=1">
<title>
<![CDATA[
Sex specificity in DNA Methylation Profiles of Neonates Following Early Preterm Birth 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367906v1?rss=1
</link>
<description><![CDATA[
Preterm birth (PTB) affects 11% of pregnancies worldwide, yet the biological mechanisms underlying its etiology remain unclear. We conducted a sex-stratified epigenome-wide association study of newborn saliva DNA methylation in 273 mother-child pairs from the Peruvian Placental Abruption Genetic Epidemiology (PAGE) study. Robust linear regression models adjusted for maternal, cellular, and technical factors identified 318 and 542 ePTB-associated CpG sites and 784 and 1,401 differentially methylated regions in boys and girls, respectively, with limited overlap between sexes. Functional analyses revealed enrichment of signals in Open Sea regions and pathways related to neurodevelopment, neural function, fetal growth, cellular organization, transcription factors, and microRNAs. Several associations replicated findings from prior studies of PTB, gestational age, and post-menstrual age. These results identify sex-specific epigenetic signatures of ePTB in an Admixed-American population and highlight developmental and regulatory pathways associated with ePTB.
]]></description>
<dc:creator><![CDATA[ Jampolskis, N., Elliott, H. R., Williams, M. A., Sanchez, S. E., Ortega, R., Jimenez Sanchez, M. L., Gelaye, B., Juvinao-Quintero, D. L. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367906</dc:identifier>
<dc:title><![CDATA[Sex specificity in DNA Methylation Profiles of Neonates Following Early Preterm Birth]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367852v1?rss=1">
<title>
<![CDATA[
A deterministic framework for linkage of infectious disease surveillance and national mortality records: development and validation using tuberculosis surveillance data 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367852v1?rss=1
</link>
<description><![CDATA[
Background: Linkage of infectious-disease surveillance data to mortality records is important for estimating long-term outcomes, but incomplete personal identifiers present methodological challenges. We developed and validated a deterministic linkage framework for linking the National Tuberculosis Surveillance System (NTBS) with Office for National Statistics (ONS) mortality records. Methods: TB notifications in England from 2001 to 2024 were linked to ONS mortality records using 12 sequential matching rules based on combinations of NHS number, date of birth, name, postcode, sex and phonetic matching. Linkage outputs underwent person level deduplication and clerical review. Precision and recall were estimated, and potential linkage bias assessed by variation in identifier completeness and linkage success. Confirmed false-positive links identified during validation were removed from the analytical dataset. Results: Among 151,965 TB notifications, 28,060 initial links were identified. Following deduplication, validation and refinement, 26,937 linked notifications were retained. Estimated precision increased from 97.7% to 99.2% (95% CI 96-100.0) following removal of false-positive links; estimated recall was 98.1% (95% CI 95.4-98.6%). More than 90% of links used NHS-number-based match keys. PDS enrichment increased NHS-number availability and enabled additional NHS-number-based links, although a small proportion linked to different ONS records following enrichment. NHS number availability and linkage success differed across demographic and social groups, demonstrating differential linkage. Conclusions: A hierarchical deterministic approach combined with targeted validation achieved high linkage accuracy while identifying and addressing differential linkage. This provides a transparent framework for future NTBS-ONS linkage and may be adaptable to other surveillance systems where comparable identifiers are available.
]]></description>
<dc:creator><![CDATA[ Presslie, O., O'Reilly, A., Zenner, D., Meghji, J., Pareek, M., Cox, S. E. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367852</dc:identifier>
<dc:title><![CDATA[A deterministic framework for linkage of infectious disease surveillance and national mortality records: development and validation using tuberculosis surveillance data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367940v1?rss=1">
<title>
<![CDATA[
Real-world effectiveness of nirsevimab over three RSV seasons in an integrated health care system: a target trial emulation study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367940v1?rss=1
</link>
<description><![CDATA[
Most nirsevimab effectiveness estimates come from test-negative designs, which restrict populations to those seeking healthcare and testing. We estimated nirsevimab effectiveness among infants six months post-receipt using a target trial emulation with an estimand aligned to phase 3 trials. We emulated a target trial among infants born from February 2, 2023 through May 30, 2026, using electronic medical records at Kaiser Permanente Georgia. Using a g-computation estimator with Cox models fit separately in nirsevimab recipients and non-recipients, we estimated the cumulative incidence of RSV hospitalization and medically-attended RSV at 30-day intervals through 180 days post-receipt. Among 4,826 infants, nirsevimab reduced the risk of RSV hospitalization by 95% (95% CI: 84% to 98%) and medically-attended RSV by 67% (95% CI: 45% to 80%) at 180 days post-receipt. The number needed to immunize to prevent one case was 147 (95% CI: 94 to 333) for RSV hospitalization and 39 (95% CI: 28 to 68) for medically-attended RSV. Nirsevimab was effective through 180 days post-receipt. This cohort-based emulation avoids conditioning on testing and the restricted generalizability of the test-negative and matching-based designs that dominate the literature. These findings support continued nirsevimab use to protect infants against RSV.
]]></description>
<dc:creator><![CDATA[ Kim, S. S., Wu, E., Hudgins, A. F., Crawford, M., Bruck, M., Lobelo, F., Benkeser, D., Rogawski McQuade, E. T. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367940</dc:identifier>
<dc:title><![CDATA[Real-world effectiveness of nirsevimab over three RSV seasons in an integrated health care system: a target trial emulation study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367922v1?rss=1">
<title>
<![CDATA[
Intersectional inequalities in demand satisfied by modern contraceptive methods among women in sub-Saharan Africa, 1994 to 2024: a multilevel analysis of individual heterogeneity and discriminatory accuracy 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367922v1?rss=1
</link>
<description><![CDATA[
Background: Demand for family planning satisfied by modern methods is Sustainable Development Goal (SDG) indicator 3.7.1, and countries have committed to universal access to family planning by 2030. Inequalities are usually reported one social dimension at a time. This hides how social characteristics combine and leaves open whether programmes should target social groups or strengthen services for all women. We measured intersectional inequalities in demand satisfied by modern methods among women in sub-Saharan Africa over three decades, assessed how well social position discriminates between women, and identified groups left behind. Methods and findings: We did a preregistered cross-sectional analysis of 139 Demographic and Health Surveys from 38 countries with fieldwork from 1994 to 2024. We included 675,584 women aged 15-49 years with demand for family planning and grouped them into 144 intersectional strata by age, union status, education, household wealth and residence. We fitted multilevel logistic models with random effects for strata and surveys (multilevel analysis of individual heterogeneity and discriminatory accuracy, MAIHDA) and estimated the variance partition coefficient (VPC), the area under the curve (AUC) and the proportional change in variance (PCV). Weighted demand satisfied rose from 27.5% in 1994-99 to 54.1% in 2018-24. Predicted demand satisfied ranged from 13.2% (95% CI: 11.0 - 15.9) among married adolescents with no schooling in the poorest rural households to 68.0% (95% CI: 63.6 - 72.0) among unmarried urban women aged 25-34 years with secondary schooling in the richest households. The strata explained only 6.9% (95% CI: 5.6 - 8.7) of individual variation, with small discriminatory accuracy (AUC = 0.65; 95% CI: 0.63 - 0.66), and a Bayesian model gave a similar VPC (7.0%; 95% credible interval: 5.7 - 8.9). Additive effects explained 95.1% of the between-stratum variance. The VPC fell from 10.1% (95% CI: 8.0 - 12.8) in 1994-99 to 4.5% (95% CI: 3.6 - 5.8) in 2018-24. Five strata of married rural women with no schooling were in the lowest decile in every period. In the latest surveys, married rural women aged 15-24 years with no schooling had lower demand satisfied than other women in 29 of 30 countries (median gap 17.5 percentage points). The 15 most disadvantaged strata held a median 16.4% of unsatisfied demand, so targeting these groups alone would reach about one in six women whose demand is not met. The main limitations are the cross-sectional design, self-reported contraceptive use and the exclusion of 15 early surveys. Conclusions: Intersectional gaps in demand satisfied by modern methods have narrowed in sub-Saharan Africa, and most of the remaining gap between groups is additive. Social position alone discriminates poorly between women, so programmes targeted only by social group would miss most women with unmet need. This supports strengthening universal services. Within universal services, married adolescents and young women with no schooling in poor rural households have been left behind for three decades in almost every country and need priority, country-specific programmes if the 2030 targets are to be met.
]]></description>
<dc:creator><![CDATA[ Kaonga, P., Masambi, S., Nkole, M., Hazemba, A. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367922</dc:identifier>
<dc:title><![CDATA[Intersectional inequalities in demand satisfied by modern contraceptive methods among women in sub-Saharan Africa, 1994 to 2024: a multilevel analysis of individual heterogeneity and discriminatory accuracy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367975v1?rss=1">
<title>
<![CDATA[
Direction of apoB/LDL-C Discordance and Systemic Inflammation in U.S. Adults 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367975v1?rss=1
</link>
<description><![CDATA[
Background: Apolipoprotein B (apoB) and low-density lipoprotein cholesterol (LDL-C) are established biomarkers of atherosclerotic cardiovascular disease (ASCVD) that tend to be closely correlated. However, some individuals have discordant apoB and LDL-C. We evaluated whether apoB/LDL-C discordance is associated with elevated high-sensitivity C-reactive protein (hs-CRP), a key marker of systemic inflammation, in a nationally representative sample. Methods and Results: We analyzed 2226 adults aged 20 years or older from the 2015 to 2016 National Health and Nutrition Examination Survey with complete apoB, LDL-C, and high-sensitivity C-reactive protein (hs-CRP). LDL-C and apoB were converted to survey-weighted scores, and discordance was the residual of apoB regressed on LDL-C. Participants were classified as apoBhigh, LDL-C-high, or concordant (reference). The association of discordance group with elevated hs-CRP (>3 mg/L) was estimated with survey-weighted logistic regression, adjusted for age, sex, body mass index (BMI), and diabetes. Discordance was present in 26.4% of adults (13.7% apoBhigher, 12.6% LDL-C-higher). Elevated hs-CRP prevalence differed by discordance group: 47.6% (95% CI, 37.6?57.7) in the apoB-high group versus 20.5% (12.9?28.1) in the LDL-C-high group and 33.6% (29.7?37.4) in the concordant group. Relative to concordant participants, adjusted odds of elevated hs-CRP were higher for apoB-high discordance (odds ratio [OR], 1.58; 95% CI, 1.03?2.45) and lower for LDL-C-high discordance (OR, 0.49; 95% CI, 0.30?0.78). Similar results were obtained among participants not on statin therapy, with apoB-high discordance demonstrating stronger adjusted odds of elevated hs-CRP (OR, 2.02; 95% CI, 1.01?4.04). Conclusion: Discordantly high apoB relative to LDL-C is associated with systemic inflammation in a nationally representative sample of U.S. adults.
]]></description>
<dc:creator><![CDATA[ Kadiri, O., Esho, I. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367975</dc:identifier>
<dc:title><![CDATA[Direction of apoB/LDL-C Discordance and Systemic Inflammation in U.S. Adults]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26368016v1?rss=1">
<title>
<![CDATA[
Smoking trajectories and brain health in middle-aged adults: a 15-year longitudinal study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26368016v1?rss=1
</link>
<description><![CDATA[
Background. Smoking is a prevalent and preventable risk factor for poor brain health. These habits often establish in early adulthood and have lasting consequences, yet most research focuses on later-life smoking, overlooking important prevention windows. We examined smoking trajectories from early adulthood in relation to midlife brain health. Methods. In 1,900 adults (65.6% female, mean age 32.5 years) from the Dutch population-based Generation R Study (ORACLE subset), smoking was assessed five times over 15 years, from before pregnancy to midlife. K-means clustering identified smoking trajectories, alongside measures of current smoking, pack-years, and abstinence years. At mean age 47.7 years, MRI assessed gray and white matter volumes, white-matter hyperintensity volume, cerebrovascular markers, and vertex-wise cortical thickness and surface area. Findings. Five trajectories were identified: non-smoking (63%), quitting before pregnancy (12%), quitting during/after pregnancy (11%), relapsing (9%), and persistent smoking (4%). All compared with non-smoking, quitting before pregnancy was associated with 6.57 cm3 larger gray matter (95%CI[0.27,12.87],p=.041), 7.71 cm3 larger white matter (95%CI[0.77,14.65],p=.030), and larger cortical surface area in bilateral middle/inferior temporal regions. Quitting during/after pregnancy was associated with more lacunes (OR=2.39; 95%CI[1.23,4.68],p=.011), but similar brain volumes. Relapsing was associated with 0.15 standard deviations more white matter hyperintensity volume (95%CI[0.00,0.30],p=.045) and thinner regions in the right cortex. Persistent smoking had double white matter hyperintensities (0.31 standard deviations; 95%CI[0.10,0.50], p=.003) and widespread bilateral thinner cortices. Similarly, single-timepoint measures like current smoking (vs never smoking) were linked to 9.72 cm3 smaller gray matter volume (95%CI[-16.53,-2.19],p=.005), 0.17 standard deviations more hyperintensity volume (95%CI[0.03,0.32],p=.015), and widespread thinner cortices. Each additional pack-year was associated with 0.45 cm3 smaller gray matter volume (95%CI[-0.85,-0.06],p=.025); each additional abstinence year was associated with 0.01 standard deviations less hyperintensity volume (95%CI[-0.02,0.00],p=.022). Interpretation. Smoking trajectories from early adulthood and midlife are associated with midlife brain health, supporting early and sustained smoking cessation.
]]></description>
<dc:creator><![CDATA[ Schuurmans, I. K., de Ruijter, F., Wolters, F. J., Muetzel, R. L., Franken, I. H. A., Neitzel, J., Cousijn, J., El Marroun, H. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26368016</dc:identifier>
<dc:title><![CDATA[Smoking trajectories and brain health in middle-aged adults: a 15-year longitudinal study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367954v1?rss=1">
<title>
<![CDATA[
Age at Menopause and Dementia Risk: Blood-Based Biomarker Evidence from a US National Study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367954v1?rss=1
</link>
<description><![CDATA[
Importance: Earlier age at menopause associates with increased later life dementia risk, but the biological links that underlie this relationship remain poorly understood in population-based samples. Objective: To evaluate the relationship between history of menopausal timing and AD/ADRD-related blood-based biomarkers in postmenopausal women. Design: Observational study using the U.S. Health and Retirement Study. AD/ADRD-related biomarkers were measured from venous blood draws conducted in 2016 and released in 2025. We estimated linear and nonlinear associations between spontaneous menopause timing and biomarkers, accounting for sociodemographic and health covariates. We evaluated effect modification by APOE {varepsilon}4 carrier status. Secondary analyses evaluated associations with hysterectomy history. Setting: Population-based. Participants: Community-dwelling post-menopausal women aged 65 years or older. Exposure: Primary: Self-reported spontaneous age of menopause among women with no history of hysterectomy. Secondary: Self-reported history of hysterectomy (oophorectomy history was not assessed). Main Outcomes and Measures: Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) measured in plasma, and phosphorylated tau (p-tau181) and growth differentiation factor 15 (GDF-15), measured in serum, by Simoa or ELLA. Results: Among 1449 women [&ge;]65 years, 38.4% self-reported a hysterectomy. Among 893 postmenopausal women without a history of hysterectomy (mean [SD] age at biomarker collection, 75.2 [7.2] years; mean age at menopause, 50.2 [5.2] years), menopausal timing was nonlinearly associated with NfL. Between menopausal ages 45-50, menopause timing was associated with higher NfL (0.010 SD units/year, [95% CI: -0.007, 0.027]), while from menopausal ages 50-55, the association reversed (b= -0.031, [95% CI: -0.051, -0.011]). Associations with GFAP or pTau-181 were not significant, but were directionally similar to those observed for NfL. Later menopausal timing linearly associated with lower GDF-15 (b = -0.015, [95% CI: -0.027, -0.004]). Self-reported hysterectomy was associated with higher GDF-15 (b= 0.118, [95% CI: 0.015, 0.220]), but not other biomarkers. Associations did not significantly differ by APOE {epsilon}4 status. Conclusions and Relevance: In a nationally representative study, earlier age at menopause in midlife was associated with later life AD/ADRDs biomarkers reflecting neuroaxonal degeneration and inflammation, underscoring the importance of understanding reproductive aging in dementia risk.
]]></description>
<dc:creator><![CDATA[ Gutierrez, S., Caunca, M. R., Guo, M., Hayes-Larson, E., Milani, S. A., Gilsanz, P., Torres, J. M., Casaletto, K. B. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367954</dc:identifier>
<dc:title><![CDATA[Age at Menopause and Dementia Risk: Blood-Based Biomarker Evidence from a US National Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367949v1?rss=1">
<title>
<![CDATA[
Weighting the weeks that matter: entropic tilting for epidemic forecast evaluation 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367949v1?rss=1
</link>
<description><![CDATA[
The performance of infectious disease forecasting models is commonly calculated under the implicit assumption that forecast accuracy is equally important across time. This approach may obscure or under-weight differences in model performance during the epidemic periods that matter most for public-health decisions. Here, we introduce the weighted prequential score (WPS), a forecast evaluation framework that can emphasize epidemic periods of interest. The WPS is a weighted average of scores over time, where weights are constructed through entropic tilting which up-weights priority periods while keeping the WPS as close as possible to the arithmetic average. We demonstrate the WPS on forecasts of incident hospitalizations submitted to the CDC FluSight challenge, focusing on two priority periods: weeks of rapid growth in incidence and weeks near the seasonal peak. Across season-location-horizon pairs, doubling the weight assigned to priority periods changes the top-ranked model in 10%-26% of eligible settings, while the top-ranked model remains unchanged regardless of the amount of weight assigned in 37%-68% of settings. We demonstrate that for suitable weights, the models favored by the WPS yield an average gain in accuracy during priority periods that is at least as large as the average accuracy lost during the remaining weeks. Because weights can be defined using observed outcomes, the WPS is not a proper scoring rule. Hence, we recommend using the WPS as a retrospective evaluation diagnostic. The WPS can guide public-health practitioners in selecting models that perform well during periods most relevant to their decisions, while encouraging forecasting teams to improve accuracy during these critical weeks.
]]></description>
<dc:creator><![CDATA[ Mathews, J. R., Lessler, J., Lemaitre, J. ]]></dc:creator>
<dc:date>2026-11-15</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367949</dc:identifier>
<dc:title><![CDATA[Weighting the weeks that matter: entropic tilting for epidemic forecast evaluation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.13.26367733v1?rss=1">
<title>
<![CDATA[
Type 2 Diabetes Mellitus and Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.13.26367733v1?rss=1
</link>
<description><![CDATA[
Epidemiologic studies suggest that type 2 diabetes mellitus (T2DM) is associated with an increased risk of colorectal cancer (CRC). However, prior meta-analyses have relied heavily on studies published more than a decade ago and have often combined distinct epidemiologic effect measures. We conducted an updated systematic review and meta-analysis of observational studies published from January 2012 through January 2026 evaluating the association between T2DM and incident CRC. PubMed, Embase, Web of Science, CENTRAL, and Scopus were searched, and eligible studies reporting associations between T2DM and CRC were included. Effect estimates were synthesized separately using random-effects models to calculate pooled estimates with 95% confidence intervals (CIs). Sex-specific and leave-one-out sensitivity analyses were also conducted. Fourteen studies were included, comprising nine cohort and five case-control studies; six reported odds ratios (ORs), seven reported hazard ratios (HRs), and one reported a standardized incidence ratio (SIR). T2DM was associated with higher odds of incident CRC (OR, 1.28; 95% CI, 1.13-1.46) and a higher hazard of incident CRC (HR, 1.27; 95% CI, 1.23-1.31). The study reporting an SIR also showed higher CRC incidence among individuals with T2DM (SIR, 1.40; 95% CI, 1.39-1.45). Sex-specific analyses generally showed positive associations in both females and males, and sensitivity analyses supported the robustness of the pooled findings. Overall, T2DM was associated with an increased risk of incident CRC, with a consistent direction of association across distinct epidemiologic effect measures. These findings provide updated evidence supporting consideration of T2DM as a marker of increased CRC risk and may inform CRC prevention strategies among individuals with T2DM.
]]></description>
<dc:creator><![CDATA[ Wang, S., Porter, A., Ge, L. ]]></dc:creator>
<dc:date>2026-11-13</dc:date>
<dc:identifier>doi:10.64898/2026.11.13.26367733</dc:identifier>
<dc:title><![CDATA[Type 2 Diabetes Mellitus and Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367860v1?rss=1">
<title>
<![CDATA[
Prevalence of Self-Reported Auditory Dysfunction Among Call Center Employees and Its Association with Shift Work Across Various Call Centers in Cairo, Egypt, March 2026 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367860v1?rss=1
</link>
<description><![CDATA[
BackgroundThe rapid, unregulated expansion of the call center industry in developing countries has increased occupational health risks for young adults, particularly with regard to auditory health.

Prolonged exposure to acoustic trauma, long working hours, and the high intensity nature of call center work can negatively affect young adults at the start of their working lives and may contribute to permanent noise induced hearing loss (NIHL). This damage is often irreversible but preventable if identified at an early stage. This study aims to evaluate the burden of auditory impairment among call center employees in Egypt and to propose evidence based mitigation strategies.

MethodsA pilot cross sectional study was conducted among employees of various medical call centers over approximately three months (January to March 2026). Participants were recruited through voluntary (self selected) sampling. Data were collected using a structured questionnaire on work history, and statistical analysis was performed to examine associations with work duration and intensity. Three semi structured, open ended interviews were conducted in March 2026 to explore the symptoms in greater depth.

ResultsForty six call center employees completed the questionnaire. The most frequently reported symptoms were mishearing words (82.6%), difficulty understanding speech in background noise (80.4%), needing others to repeat themselves (78.3%), and sensitivity to loud sounds (78.3%); 60.9% reported tinnitus.

Higher auditory symptom severity was associated with a history of acoustic shock (Mann Whitney U = 344.0, p = .004) and with greater cognitive symptom burden (Spearmans {rho} = .416, p = .004), but not significantly with shift type (p = .177), years of work (p = .885), or daily and weekly working hours. Qualitative interviews described auditory strain that builds through the shift, disrupted sleep, informal coping, and the absence of employer guidance or symptom reporting pathways.

Conclusion and RecommendationsSelf reported auditory symptoms were common in this preliminary sample of call center employees and were associated with acoustic shock exposure and cognitive symptom burden, but not significantly with shift pattern or length of service. Because the study was cross sectional, relied on self reports, and used a small volunteer sample (pilot study), the findings cannot establish causation or true prevalence. Recommended measures include acoustic shock limiters with incident reporting, audiometric screening that prioritizes at risk employees, safe volume education with regular breaks, and educational programs on auditory hazards and early warning signs to prevent actual auditory damage. Larger multi site studies with audiometric confirmation are also needed.
]]></description>
<dc:creator><![CDATA[ HAKIMHUSSIEN, M. H., abdel kareem, a., halim, a. ]]></dc:creator>
<dc:date>2026-11-13</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367860</dc:identifier>
<dc:title><![CDATA[Prevalence of Self-Reported Auditory Dysfunction Among Call Center Employees and Its Association with Shift Work Across Various Call Centers in Cairo, Egypt, March 2026]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367886v1?rss=1">
<title>
<![CDATA[
Pneumococcal nasopharyngeal carriage in children 2-60 months of age in Novi Sad (Serbia), October 2022-September 2026 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367886v1?rss=1
</link>
<description><![CDATA[
BackgroundStreptococcus pneumoniae nasopharyngeal carriage in young children is an important source of transmission and may precede pneumococcal disease. Pneumococcal conjugate vaccines can alter circulating serotypes. Continued surveillance is needed to monitor serotype replacement, vaccine serotype coverage, and antimicrobial resistance.

MethodsA prospective surveillance study was conducted in outpatient pediatric practices from October 2022 to September 2026 among children aged 2-60 months in Novi Sad, Serbia. Healthy children attending preventive visits and children with acute respiratory tract infections were enrolled. Nasopharyngeal specimens were collected and cultured for S. pneumoniae. Participant-level analyses used the first eligible specimen per child, while isolate-level analyses included all recovered isolates. Serotyping and antimicrobial susceptibility testing were performed. Theoretical vaccine serotype coverage was estimated for licensed and selected investigational pneumococcal conjugate vaccines, with 23- valent polysaccharide vaccine evaluated separately.

ResultsAmong 3,373 included children, 911 were pneumococcal carriers, giving an overall carriage prevalence of 27.0%. Carriage was higher among children with acute respiratory tract infection than among healthy children and was also associated with daycare attendance, chronic medical conditions, age, season, and surveillance year. In total, 1,312 pneumococcal isolates were recovered, of which 87.9% were typeable. The most frequent serotypes included 11A, 10A, 15A, 15B, 23A, 23B, 19A, and 6B. Theoretical serotype coverage was 8.2% for PCV10, 17.5% for PCV13, 20.0% for PCV15, and 47.3% for PCV20. More than half of typeable isolates were non-PCV20 serotypes. Resistance was most frequent to erythromycin, clindamycin, and tetracycline, while multidrug resistance was observed in 18.1% of isolates. Penicillin G non-susceptibility was uncommon.

ConclusionPneumococcal carriage in children aged 2-60 months in Novi Sad was associated with age, clinical presentation, season, and surveillance year and involved diverse serotypes. Continued carriage surveillance, linked with invasive-disease and antibiotic-use data, would help determine whether the observed serotype and resistance patterns persist.
]]></description>
<dc:creator><![CDATA[ Petrovic, V. J., Milosavljevic, B., Djilas, M., Markovic, M., Vukovic, V., Pustahija, T., Rajcevic, S., Medic, S., Djekic-Malbasa, J., Gvozdenac-Dragicevic, G., Lazarevic, J., Zelenovic, M., Bjelic-Novakovic, R., Trivic, S., Kopcanski, S., Andric, V., Ristic, M. ]]></dc:creator>
<dc:date>2026-11-13</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367886</dc:identifier>
<dc:title><![CDATA[Pneumococcal nasopharyngeal carriage in children 2-60 months of age in Novi Sad (Serbia), October 2022-September 2026]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367750v1?rss=1">
<title>
<![CDATA[
Socioeconomic position, socioenvironmental conditions, and subjective cognitive decline among midlife and older LGBTQIA+ adults in California 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367750v1?rss=1
</link>
<description><![CDATA[
ObjectivesTo examine which measure of socioeconomic position and socioenvironmental conditions has the strongest relationship with subjective cognitive decline (SCD) among midlife and older lesbian, gay, bisexual, transgender, queer, intersex, asexual, and other sexual and gender minority (LGBTQIA+) adults.

MethodsWe conducted a cross-sectional analysis of 3869 LGBTQIA+ adults aged 50 years or older participating in a community-engaged survey in California. Using logistic regression, we examined overall associations between each indicator of socioeconomic position and socioenvironmental conditions and SCD. We used a dominance analysis to assess the relative importance of each indicator based on the proportion of variance in SCD it explained.

ResultsOverall, 14.7% of the sample reported SCD. Midlife and older LGBTQIA+ adults in a lower socioeconomic position (i.e., lower education, unemployment, lower household income, fewer assets, financial insecurity, food insecurity, and unstable housing) had higher odds of SCD than those in a higher position, with significant odds ratios (OR) ranging from 1.28 to 2.55. In contrast, perceiving ones community as safe for LGBTQIA+ people was associated with lower odds of SCD (OR 0.47; 95% CI 0.38, 0.58). Dominance analysis indicated that household assets was the most important factor, explaining 4.4% of the variance in SCD (95% CI 3.5%, 5.4%), followed by household income (2.9%; 95% CI 2.2%, 3.8%) and perceived community safety (2.2%; 95% CI 1.4%, 3.1%).

DiscussionSupporting the cognitive health of LGBTQIA+ people may require attention to both financial security across the life course and the broader social environments.
]]></description>
<dc:creator><![CDATA[ Tran, N. K., Cicero, E., Rosendale, N., Sunder, G., Dawson-Rose, C., Flentje, A. ]]></dc:creator>
<dc:date>2026-11-13</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367750</dc:identifier>
<dc:title><![CDATA[Socioeconomic position, socioenvironmental conditions, and subjective cognitive decline among midlife and older LGBTQIA+ adults in California]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.12.26367895v1?rss=1">
<title>
<![CDATA[
Epidemiology of zero-dose among children aged 12-35 months in Ethiopia: Burden, correlates and spatial patterns; Evidence from a 2025 national survey 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.12.26367895v1?rss=1
</link>
<description><![CDATA[
BackgroundChildren who have not received the first dose of a diphtheria-tetanus-pertussis-containing vaccine are classified as zero-dose. Understanding how many children remain without this dose beyond infancy, the correlates, and their geographic distribution can inform routine and catch-up vaccination services in Ethiopia. This study aimed to estimate the burden of zero-dose, identify its correlates, and map its spatial distribution among children aged 12-35 months in Ethiopia.

MethodsWe analyzed data from 2,097 children aged 12-35 months in the Pathways for Ethiopia survey, a recent national population-based cross-sectional household survey conducted from August to November 2025. The burden estimates and regression analyses accounted for sampling weights, stratification, and clustering. Adjusted prevalence ratios (aPRs) were obtained through marginal standardization of survey-weighted logistic regression models. Spatial autocorrelation, hotspot, and spatial-scan analyses assessed geographic clustering. Ordinary kriging predicted prevalence at unsampled locations.

ResultsThe weighted prevalence of zero-dose status was 20.6% (95% confidence interval [CI]: 15.9-26.3), with regional point estimates ranging from 0.8% in Addis Ababa to 35.9% in Somali. Its burden was 20.4% among children aged 12-23 months and 20.8% among those aged 24-35 months. Higher burden was associated with no antenatal care compared with four or more visits (aPR: 2.39; 95% CI: 1.61-3.53), unimproved compared with improved drinking-water sources (aPR: 1.52; 95% CI: 1.18-1.97), and caregivers rating vaccination as less than very important compared with very important (aPR: 2.68; 95% CI: 2.03-3.54). Zero-dose prevalence showed significant spatial clustering (Morans I = 0.229; p = 0.0001). Hotspots occurred among sampled communities in Somali, Oromia, Central Ethiopia, Afar, and South Ethiopia. Predicted prevalence was highest across parts of eastern and south-central Ethiopia.

ConclusionApproximately one in five children aged 12-35 months had not received the first pentavalent dose. High zero-dose prevalence clustered among sampled communities in eastern and south-central Ethiopia. Moreover, antenatal care and drinking water source were independent factors. Immunization programs should prioritize these communities for identifying and vaccinating missed children, including those aged 24-35 months.
]]></description>
<dc:creator><![CDATA[ Geleso, M. G., Shiferie, F., Worku, A., Asres, A., Astatkie, A., Shumet, T., Tsegaye, D. A., Andargie, G., Gebremedhin, S. ]]></dc:creator>
<dc:date>2026-11-13</dc:date>
<dc:identifier>doi:10.64898/2026.11.12.26367895</dc:identifier>
<dc:title><![CDATA[Epidemiology of zero-dose among children aged 12-35 months in Ethiopia: Burden, correlates and spatial patterns; Evidence from a 2025 national survey]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367258v1?rss=1">
<title>
<![CDATA[
Associations between different intensities of leisure-time physical activity and subsequent psychotropic medication use among young and early midlife adults: a register-linked follow-up study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367258v1?rss=1
</link>
<description><![CDATA[
IntroductionPrevious studies have not examined associations between physical activity intensity and subsequent psychotropic medication use. We examined associations between different leisure-time physical activity (LTPA) intensities and subsequent psychotropic medication purchases.

MethodsWe used Helsinki Health Study questionnaire data collected in 2017 from 19-39-year-old employees of the City of Helsinki, linked to register data on psychotropic medication purchases from 2014 to 2022 (82.5% consented to the register linkage). The analytical sample included 4,160 participants (80.4% women, representing the target population). Weekly hours of light (LPA), moderate (MPA) and vigorous (VPA) LTPA were examined separately. Cox proportional hazards regression with restricted cubic splines was used to examine nonlinear associations with the first psychotropic medication purchase during follow-up, adjusting for prior medication and sociodemographic and health-related covariates. Hazard ratios (HRs) and 95% confidence intervals (CIs) were reported.

ResultsDuring the follow-up, 28.1% of participants had at least one psychotropic medication purchase. After adjustment for age and gender, VPA was associated with psychotropic medication purchases (overall p<0.001; nonlinearity p<0.001), whereas MPA and LPA were not. Further adjustments and stratification by prior psychotropic medication purchase status attenuated the VPA association (overall p=0.0041). In this model, for 5 versus 0 hours/week of VPA, the HR was 0.79 (95% CI 0.68-0.91), corresponding to approximately 23 fewer first-purchase events per 1,000 participants over three years.

ConclusionsHigher-intensity LTPA appeared more strongly associated with a lower hazard of psychotropic medication purchases, although only the VPA association saw clear support.
]]></description>
<dc:creator><![CDATA[ Jarvensivu, L., Paivarinne, V., Rahkonen, O., Lallukka, T. ]]></dc:creator>
<dc:date>2026-11-12</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367258</dc:identifier>
<dc:title><![CDATA[Associations between different intensities of leisure-time physical activity and subsequent psychotropic medication use among young and early midlife adults: a register-linked follow-up study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.10.26367785v1?rss=1">
<title>
<![CDATA[
Beyond the 24-Hour Rhythm: Functional Principal Components of Daily Activity Residuals and Mortality in NHANES 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.10.26367785v1?rss=1
</link>
<description><![CDATA[
BackgroundAccelerometer-derived 24-hour activity profiles are usually summarised by cosinor rhythm parameters or by functional principal component analysis (FPCA). Applied to the raw profiles, however, the leading functional components largely re-express what the cosinor already captures: activity level, rhythm strength and timing. Whether the shape of the day carries health information beyond these parameters is unclear.

MethodsWe analysed adults with seven valid days of accelerometry from two National Health and Nutrition Examination Survey (NHANES) cohorts: hip activity counts (2003-2006; n = 2,615) and wrist Monitor-Independent Movement Summary units (2011-2014; n = 3,208). Minute-level activity was transformed with the inverse hyperbolic sine, and a single 24-hour cosinor curve was fitted across each participants seven days. Each participants average residual curve, which contains no 24-hour component, was decomposed by FPCA and, to separate stable between-person patterns from day-to-day variation, by multilevel FPCA. In exploratory analyses, we related the three leading components to all-cause mortality and, secondarily, to cardiovascular and cancer mortality. We used Cox proportional hazards models adjusted for age, sex, race/ethnicity, income and the cosinor parameters, with the hip cohort for discovery and the wrist cohort for replication.

ResultsThe three leading residual components explained 44% (hip) and 51% (wrist) of residual variance and consisted mainly of 12-hour and 8-hour patterns. The second component (FPC2) contrasts an early-starting, flat day with a day of distinct mid-morning and evening peaks. Its shape was nearly identical in the two cohorts (similarity 0.96), and multilevel FPCA recovered it as a stable between-person pattern. In unweighted models, FPC2 was the only component associated with all-cause mortality in the discovery cohort (hazard ratio per SD 1.17, 95% CI 1.06 to 1.29; Benjamini-Hochberg q = 0.008), and the association replicated in the wrist cohort (1.18, 1.03 to 1.35; p = 0.017). With survey weights that also accounted for selection into the analytic sample, the association was concentrated in cardiovascular deaths (hip 1.53, 1.12 to 2.09, p = 0.007; wrist 1.38, 1.10 to 1.72, p = 0.005). This association persisted after further adjustment for lifestyle factors and traditional activity metrics. FPC2 was not associated with cancer mortality. Scores of the leading components did not form distinct clusters (average silhouette width[&le;] 0.23), but FPC2 was selected as a continuous predictor of cardiovascular mortality in both cohorts by forward selection on 10-fold cross-validated, survey-weighted AUC.

ConclusionsThe within-day structure of activity that a 24-hour cosinor cannot represent varies continuously between people. One replicated aspect of it, the loss of a two-peak daily pattern, was associated with mortality beyond rhythm strength and timing, most clearly cardiovascular mortality. The shape of daily activity therefore carries prognostic information beyond standard rhythm summaries. It can support mortality risk prediction that needs only a few personal details, and may help identify individuals at elevated risk and tailor interventions to their daily activity patterns.
]]></description>
<dc:creator><![CDATA[ Zheng, X. ]]></dc:creator>
<dc:date>2026-11-12</dc:date>
<dc:identifier>doi:10.64898/2026.11.10.26367785</dc:identifier>
<dc:title><![CDATA[Beyond the 24-Hour Rhythm: Functional Principal Components of Daily Activity Residuals and Mortality in NHANES]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367828v1?rss=1">
<title>
<![CDATA[
Resting Heart Rate for Global Health Surveillance: Descriptive Epidemiology of 566,986 Participants from the WHO STEP Surveys and the South Asia Biobank 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367828v1?rss=1
</link>
<description><![CDATA[
ObjectiveTo describe global patterns of resting heart rate (RHR) in population subgroups and over time.

MethodsObservational data from WHO STEP surveys (n=363,462 participants from 76 countries, 2002-2020) and the South Asia Biobank (SAB, n=203,524 participants from four South Asian countries, 2018-2023). RHR was measured in triplicate while seated using a blood pressure cuff. Height and weight were measured using anthropometric techniques. Physical activity was self-reported and accelerometry-measured (SAB subsample, n=22,183). We describe RHR distributions by geographical region, temporality, sex, age, BMI, and physical activity. Utility of RHR to explain accelerometer-based physical activity was examined by regression.

ResultsCountry-level median RHR ranged 65-80 bpm, higher in women than men. Age-related RHR patterns diverged markedly by sex; men showing a curvilinear association with higher RHR in midlife, and women showing a consistent decline with age across most regions. Compared to normal-weight, obese participants had higher RHR [WHO: (men: +4.4 bpm, women: +0.9 bpm, SAB: (men: +3.1 bpm, women: +1.0 bpm)]. Participants meeting physical activity recommendations had lower RHR [WHO: (men -1.6 bpm, women: -0.9 bpm), SAB: (men: -2.1 bpm, women: -0.5 bpm)] compared to insufficiently active. In SAB (field-work spanning whole-calendar year), seasonal variations were present (0.6-0.9 bpm higher RHR in June-August compared to the Sept-Nov period), most pronounced further from the equator. In 21 WHO countries with repeat survey data, RHR was stable over time in women but declined in men (-0.4 bpm/year). Self-reported activity explained 2-14% (women: 2-3%, men: 10-14%) of the variance in device-measured physical activity, and RHR added 1-3% incrementally.

ConclusionsRHR varies globally, exhibits different age-related patterns by sex, and is higher in population subgroups with greater non-communicable disease burden. RHR is easy to measure and may have utility for global health surveillance.
]]></description>
<dc:creator><![CDATA[ Alshallal, A. D., Gonzales, T. I., Siahaan, A., Xie, W., Foley, L., Avari, P., Pradeepa, G., Mahmood, S., Butt, A., De Silva, L., Chandrathilake, M., Tyagi, A., Loomba, M., Hasan, M., Ahsan, A., Sarker, T., Loh, M., Ahmed, S., Kasturiratne, A., Mridha, M. K., Anjana, R. M., Katulanda, P., Jha, V., Khawaja, K. I., Chambers, J. C., Brage, S., WHO Country Data Author Group,, South Asia Biobank Study Group ]]></dc:creator>
<dc:date>2026-11-12</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367828</dc:identifier>
<dc:title><![CDATA[Resting Heart Rate for Global Health Surveillance: Descriptive Epidemiology of 566,986 Participants from the WHO STEP Surveys and the South Asia Biobank]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.11.26367838v1?rss=1">
<title>
<![CDATA[
El Nino Southern Oscillation shapes cholera in Africa 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.11.26367838v1?rss=1
</link>
<description><![CDATA[
Cholera is considered a paradigm for climate-sensitive diseases, yet its relation with El Nino Southern Oscillation (ENSO), the dominant mode of interannual climate variability, remains poorly quantified in Africa where most cholera deaths occur. Using 15 years of surveillance data across 30 African countries and novel statistical and simulation frameworks, we identify five geographically coherent ENSO-cholera teleconnection groups, each characterized by distinct directions, strengths and timing of effects on outbreak occurrence, duration and incidence. For the unfolding major El Nino of 2026-27, we project two- to five-fold greater cholera burden in Eastern and Horn of Africa than under ENSO-neutral conditions. These findings identify immediate priorities for anticipatory action and establish a dynamic framework for attributing burden for outbreak-prone diseases to climate variability.
]]></description>
<dc:creator><![CDATA[ Perez-Saez, J., Lee, E. C., Zheng, Q., Kamadjeu, R., Zaitchik, B. F., Azman, A. S. ]]></dc:creator>
<dc:date>2026-11-12</dc:date>
<dc:identifier>doi:10.64898/2026.11.11.26367838</dc:identifier>
<dc:title><![CDATA[El Nino Southern Oscillation shapes cholera in Africa]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://www.medrxiv.org/content/10.64898/2026.11.10.26367783v1?rss=1">
<title>
<![CDATA[
Factors associated with congenital syphilis among women with gestational syphilis in a public health network in Bogota, Colombia, 2017-2024: A case-control study 
]]>
</title>
<link>
https://www.medrxiv.org/content/10.64898/2026.11.10.26367783v1?rss=1
</link>
<description><![CDATA[
BackgroundCongenital syphilis remains a preventable cause of perinatal morbidity and mortality, and its incidence in Colombia remains well above the elimination target. We aimed to identify maternal and prenatal care factors associated with congenital syphilis among women with gestational syphilis attended in a public health network serving socially vulnerable populations in Bogota, Colombia.

MethodsWe conducted a retrospective case-control study using surveillance and clinical records from the Subred Integrada de Servicios de Salud Sur E.S.E. for pregnancies ending between 2017 and 2024. Cases were neonates with congenital syphilis according to national surveillance criteria; controls were neonates without congenital syphilis born to mothers with gestational syphilis in the same network. Factors associated with congenital syphilis were identified using multivariable logistic regression with backward elimination.

ResultsWe included 743 mother-infant pairs (285 cases and 458 controls). Maternal diagnosis after 28 weeks of gestation (adjusted odds ratio 17.75; 95% confidence interval 11.81-26.69), absence of prenatal care compared with eight or more visits (12.74; 5.03-32.25) and reinfection during pregnancy (3.02; 1.73-5.29) were independently associated with congenital syphilis, whereas a documented history of syphilis was associated with lower odds (0.45; 0.25-0.82). The model showed high discrimination (area under the receiver operating characteristic curve 0.860). Migrant status was associated with congenital syphilis in the crude analysis but not after adjustment.

ConclusionsCongenital syphilis in this setting was associated mainly with late maternal diagnosis and absent prenatal care, conditions that preclude timely benzathine penicillin treatment. Strengthening early prenatal screening, continuity of care and partner management may reduce vertical transmission in socially vulnerable urban populations.
]]></description>
<dc:creator><![CDATA[ Gomez, A. M., Olarte Escobar, N. M., Valderrama Marquez, I. A., Castellanos Corredor, J. E., Lopez Cruz, R. L., Escobar, J., Rico Mendoza, A., Porras Ramirez, A. ]]></dc:creator>
<dc:date>2026-11-12</dc:date>
<dc:identifier>doi:10.64898/2026.11.10.26367783</dc:identifier>
<dc:title><![CDATA[Factors associated with congenital syphilis among women with gestational syphilis in a public health network in Bogota, Colombia, 2017-2024: A case-control study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory</dc:publisher>
<prism:publicationDate>2026-11-12</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
